Tigemac 90mg Tablet 10s TICAGRELOR
ABOUT Tigemac 90mg Tablet 10s
Tigemac 90mg Tablet 10s is a brand name for the generic medicine Ticagrelor (90mg). Ticagrelor is used to reduce the risk of heart attack, stroke, and other heart-related complications in patients with acute coronary syndrome or a history of heart attack. It is an antiplatelet medication that works by preventing platelets in the blood from sticking together and forming clots, which can block blood flow to the heart or brain.
Tigemac 90mg Tablet 10s is available in the form of tablets, each containing 90mg of Ticagrelor. This medication is produced in India by Macleods Pharmaceuticals Pvt Ltd, a company known for its commitment to quality and innovation in the pharmaceutical industry.
Macleods Pharmaceuticals Pvt Ltd meets WHO Good Manufacturing Practice (GMP) certification criteria according to CDSCO, ensuring that Tigemac 90mg Tablet 10s is manufactured to the highest standards of quality and safety. Alternatives to Tigemac 90mg Tablet 10s include other brands containing Ticagrelor, such as Brilinta and Ticagrelor tablets by other manufacturers.
INTRODUCTION OF Tigemac 90mg Tablet 10s
Tigemac 90mg Tablet 10s is a crucial medication for individuals at risk of cardiovascular events due to its potent antiplatelet properties. This medication is primarily prescribed to patients who have experienced acute coronary syndrome, a condition characterized by reduced blood flow to the heart, often leading to heart attacks. By inhibiting platelet aggregation, Tigemac 90mg Tablet 10s helps maintain smooth blood flow, reducing the likelihood of clot formation that can lead to heart attacks or strokes.
The active ingredient, Ticagrelor, is a reversible antagonist of the P2Y12 receptor on platelets, which plays a significant role in platelet activation and aggregation. Unlike other antiplatelet drugs, Ticagrelor does not require metabolic activation, allowing for a more predictable and consistent antiplatelet effect. This makes Tigemac 90mg Tablet 10s a preferred choice for many healthcare providers when managing patients with a high risk of thrombotic events.
Patients prescribed Tigemac 90mg Tablet 10s are often those who have undergone procedures such as angioplasty or stent placement, where the risk of clot formation is heightened. The medication is typically part of a comprehensive treatment plan that includes lifestyle modifications and other medications to manage cardiovascular risk factors. Regular monitoring and follow-up with healthcare providers are essential to ensure the effectiveness and safety of the treatment regimen.
CONDITIONS TREATED BY Tigemac 90mg Tablet 10s
Tigemac 90mg Tablet 10s is primarily used to manage and prevent conditions related to acute coronary syndrome, including heart attacks and strokes. It is also prescribed to patients with a history of myocardial infarction to prevent further cardiovascular events. The medication is an integral part of the treatment plan for patients undergoing percutaneous coronary intervention (PCI) to prevent stent thrombosis.
MOLECULE NAME
Ticagrelor (90mg)
HOW IT WORKS Tigemac 90mg Tablet 10s
Tigemac 90mg Tablet 10s works by inhibiting the P2Y12 receptor on platelets, which is crucial for platelet activation and aggregation. By blocking this receptor, Ticagrelor prevents platelets from clumping together, thereby reducing the risk of clot formation. This action helps maintain smooth blood flow in the arteries, reducing the risk of heart attacks and strokes in patients with acute coronary syndrome or a history of myocardial infarction.
COMMON SIDE EFFECTS OF Tigemac 90mg Tablet 10s
Common side effects of Tigemac 90mg Tablet 10s may include shortness of breath, dizziness, headache, and increased bleeding tendency. Some patients may experience gastrointestinal symptoms such as nausea or diarrhea. It is important to report any unusual or severe side effects to a healthcare provider promptly.
HOW TO TAKE Tigemac 90mg Tablet 10s
Tigemac 90mg Tablet 10s should be taken as prescribed by a healthcare provider. It is usually taken twice daily, with or without food. Patients should follow the dosing schedule carefully and not alter the dose without consulting their doctor. It is important to continue taking the medication even if symptoms improve, as stopping it abruptly can increase the risk of a heart attack or stroke.
PRECAUTIONS OF Tigemac 90mg Tablet 10s
Before taking Tigemac 90mg Tablet 10s, patients should inform their healthcare provider of any allergies, medical conditions, or other medications they are taking. Caution is advised in patients with a history of bleeding disorders or liver problems. Regular monitoring of blood counts and liver function tests may be necessary. Patients should avoid activities that may increase the risk of bleeding and report any signs of unusual bleeding or bruising to their doctor.
FOOD & DRUG INTERACTIONS OF Tigemac 90mg Tablet 10s
Patients taking Tigemac 90mg Tablet 10s should avoid grapefruit and grapefruit juice, as they can increase the levels of Ticagrelor in the blood, leading to an increased risk of side effects. It is also important to inform healthcare providers of all medications being taken, including over-the-counter drugs and supplements, to avoid potential interactions.
ALTERNATIVE BRANDS OF Tigemac 90mg Tablet 10s
Alternative brands of Tigemac 90mg Tablet 10s include Brilinta and other Ticagrelor tablets manufactured by different pharmaceutical companies. Patients should consult their healthcare provider before switching brands to ensure the alternative is suitable for their condition.
FACT MEDICINE OF Tigemac 90mg Tablet 10s
Tigemac 90mg Tablet 10s is a vital medication for preventing cardiovascular events in high-risk patients. Its active ingredient, Ticagrelor, offers a reliable antiplatelet effect by inhibiting platelet aggregation. Manufactured by Macleods Pharmaceuticals Pvt Ltd, this medication meets high-quality standards and is a trusted choice for managing acute coronary syndrome. Patients should adhere to their prescribed regimen and consult their healthcare provider for any concerns regarding their treatment.
Can you take Brilinta and aspirin together?
Several clinical studies have investigated the effects of BRILINTA in patients with acute coronary syndrome ACS when used in combination with aspirin However it has been observed that the efficacy of BRILINTA is reduced when maintenance doses of aspirin exceed 100 mg Therefore it is advised that the daily maintenance dose of aspirin should not exceed 100 mg It is important to note that BRILINTA is classified as an antiplatelet agent and as such it carries the risk of causing significant and potentially fatal bleeding Due to the nature of its mechanism of action there is a potential for bleeding events when using BRILINTA These bleeding events can range from mild to severe and in some cases they can even be fatal Therefore it is crucial for patients and healthcare professionals to carefully monitor any signs of bleeding while using BRILINTA It is highly recommended to promptly seek medical attention if any unexplained or prolonged bleeding occurs during the treatment To ensure the safe and effective use of BRILINTA it is imperative to adhere to the prescribed dosage and follow the instructions provided by the healthcare provider Additionally patients should be thoroughly educated about the signs and symptoms of bleeding so they can identify and report any potential issues promptly By being vigilant and proactive the risk of bleeding events associated with BRILINTA can be minimized
What is a substitute for brilinta?
Plavix known as clopidogrel is a medication used as a blood thinner It is available under the brand name Plavix as well as in generic form While Brilinta is not yet available in generic form Plavix offers a more affordable alternative for those seeking a bloodthinning medication By choosing generic Plavix individuals can benefit from its effectiveness in preventing blood clots while also saving on costs Clopidogrel the active ingredient in Plavix works by inhibiting platelet aggregation which reduces the risk of clot formation in blood vessels The availability of generic Plavix provides an opportunity to access this medication at a lower price point without compromising on its effectiveness It is important to consult a healthcare professional to determine the most suitable bloodthinning medication based on individual medical needs and considerations With the option of generic Plavix patients can achieve the desired therapeutic effects while also taking advantage of the cost savings associated with generic medications
What foods should I avoid while taking brilinta?
It is essential to be cautious and refrain from consuming grapefruit juice while undergoing a course of Brilinta medication A study conducted on the subject has revealed a startling fact the consumption of grapefruit juice can actually increase the exposure of Brilinta Tigemac tablet in the body by more than twofold This amplified exposure can potentially intensify the medications effect on the inhibition of platelets and in theory elevate the chances of experiencing bleeding complications To ensure your safety and minimize any unforeseen risks it is advisable to abstain from drinking grapefruit juice while taking Brilinta By doing so you can maintain a stable and controlled level of medication in your system reducing the likelihood of any adverse bleeding events Your healthcare provider or pharmacist can provide further guidance and clarity on this matter addressing any doubts or concerns you may have Ultimately prioritizing your wellbeing and making informed choices regarding your medication regimen is crucial By making a conscious effort to avoid grapefruit juice while on Brilinta you can play an active role in safeguarding your health and minimizing any potential complications
What drugs should not be taken with brilinta?
It is advisable to refrain from the usage of potent inhibitors of CYP3A such as ketoconazole itraconazole voriconazole clarithromycin nefazodone ritonavir saquinavir nelfinavir indinavir atazanavir and telithromycin when taking BRILINTA This is due to the fact that BRILINTA undergoes metabolism with the help of CYP3A45 enzymes These inhibitors have the potential to interfere with the normal metabolic process of BRILINTA which may lead to undesirable effects or reduce the efficacy of the medication Patients who are prescribed BRILINTA should be cautious and inform their healthcare provider about any medications they are currently taking especially those containing potent CYP3A inhibitors It is important to note that this list is not exhaustive and there may be other medications or substances that can inhibit CYP3A enzymes Therefore it is crucial to consult with a healthcare professional to ensure safe and effective use of BRILINTA while avoiding any potential drug interactions By following these recommendations and staying vigilant about potential drug interactions patients can maximize the benefits of BRILINTA while minimizing any risks associated with its use Always consult with a healthcare provider for personalized advice tailored to your specific medical condition and medication regimen
Does brilinta affect the kidneys?
While Tigemac tablet has the potential to adversely affect kidney function it is important to note that no dosage adjustment is necessary for patients with renal impairment 7 This means that individuals with existing kidney dysfunction can still safely take Tigemac tablet without the need to modify the amount of medication they consume It is crucial however to closely monitor renal function in patients who are prescribed Tigemac tablet especially those with preexisting kidney issues The fact that Tigemac tablet does not require dosage adjustment in patients with renal dysfunction is significant because it simplifies the treatment process and reduces the potential for medication errors This is particularly beneficial for individuals who suffer from conditions that impact both their kidneys and their cardiovascular health as they can continue taking Tigemac tablet without added complications It is worth noting that while Tigemac tablet may have a negative impact on kidney function the overall benefits of the medication in terms of preventing heart attacks and reducing the risk of cardiovascular events outweigh the potential risks in most cases In conclusion Tigemac tablet is a medication that does not necessitate dosage adjustment in patients with renal dysfunction However it is crucial to carefully monitor kidney function in these individuals to ensure that any potential adverse effects are promptly addressed Overall the benefits of Tigemac tablet in preventing cardiovascular events make it an important treatment option for patients even those with preexisting kidney issues
What will happen if I stop taking Ticaspan?
It is crucial not to discontinue the usage of Ticaspan without consulting your healthcare provider first Discontinuing this medication without proper guidance may significantly raise the likelihood of experiencing a heart attack or stroke Additionally individuals who have had a stent placed should continue taking Ticaspan as prescribed Stopping the medication in such cases can increase the risk of developing a blood clot within the stent which could potentially lead to severe consequences like a heart attack or even death Therefore it is of utmost importance to adhere to the prescribed treatment regimen and to maintain communication with your doctor regarding any concerns or potential adjustments to your medication By prioritizing your health and following medical advice you can mitigate the risks associated with Ticaspan and ensure your wellbeing
Similar Medicines
Ticagrelor (90mg)
Ticagrelor (90mg)
Ticagrelor (90mg)
Ticagrelor (90mg)
Ticagrelor (90mg)
More medicines by Macleods Pharmaceuticals Pvt Ltd
Levosulpiride (75mg) + Pantoprazole (40mg)
Levosulpiride (75mg) + Esomeprazole (40mg)
Dapagliflozin (10mg) + Metformin (500mg)
Cefepime (1000mg) + Tazobactum (125mg)
Cinitapride (3mg) + Pantoprazole (40mg)
.svg)
